Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | F7 | P08709 | 4/20 | 0.63 |
| ▸ | F3 | P13726 | 4/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.63 |
| ▸ | PPARG | P37231 | 4/20 | 0.63 |
| ▸ | PPARD | Q03181 | 4/20 | 0.63 |
| ▸ | PPARA | Q07869 | 4/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.63 |
| ▸ | BLM | P54132 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.63 |
| ▸ | RECQL | P46063 | 2/20 | 0.63 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9281846 | 1.00 | ALDH1A1 (0.63) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL15901156 | 1.00 | ALDH1A1 (0.63) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL16090824 | 1.00 | ALDH1A1 (0.63) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL12525345 | 1.00 | ALDH1A1 (0.63) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL16090823 | 1.00 | ALDH1A1 (0.63) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL26914644 | 1.00 | ALDH1A1 (0.63) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL15901154 | 1.00 | ALDH1A1 (0.63) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL811915 | 0.98 | ALDH1A1 (0.60) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL811916 | 0.98 | ALDH1A1 (0.60) | ALDH1A1F7F3MAPTHSD17B10 | |
| SCHEMBL23950586 | 0.94 | ALDH1A1 (0.73) | ALDH1A1F7F3MAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9758543-B2 | Alkenyl glycosides and their preparation | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-9481850-B2 | Maleinized ester derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-11-01 | — | — | US | disclosed |
| US-9464255-B2 | Maleinized ester derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-10-11 | — | — | US | disclosed |
| US-20160215233-A1 | Maleinized Ester Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| US-20160200756-A1 | Alkenyl Glycosides and Their Preparation | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-07-14 | — | — | US | disclosed |
| US-20160200999-A1 | Maleinized Ester Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-07-14 | — | — | US | disclosed |
| US-9321985-B1 | Laundry detergents based on compositions derived from natural oil metathesis | STEPAN COMPANY (US) | 2016-04-26 | — | — | US | disclosed |
| US-9266918-B2 | Alkenyl glycosides and their preparation | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150307469-A1 | Glycitan Esters of Unsaturated Fatty Acids and Their Preparation | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-10-29 | — | — | US | disclosed |
| US-9045447-B2 | Glycitan esters of unsaturated fatty acids and their preparation | Elevance Renewable Sicences, Inc. (US) | 2015-06-02 | — | — | US | disclosed |
| US-20150057204-A1 | Maleanized Ester Derivatives | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-02-26 | — | — | US | disclosed |
| WO-2014159226-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| WO-2014159211-A1 | ALKENYL GLYCOSIDES AND THEIR PREPARATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20140275580-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275506-A1 | ALKENYL GLYCOSIDES AND THEIR PREPARATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140274832-A1 | MALEINIZED ESTER DERIVATIVES | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275580-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | SGMS1, SCD5, FADS1 | ALDH1A1 1724/4885F7 1049/4885F3 1298/4885 |
| US-20160200999-A1 | Maleinized Ester Derivatives | ADH5, MLEC, ADH1A | ALDH1A1 17/4885F7 336/4885F3 1054/4885 |
| US-20150307469-A1 | Glycitan Esters of Unsaturated Fatty Acids and Their Preparation | SGMS1, SCD5, FADS1 | ALDH1A1 1724/4885F7 1049/4885F3 1298/4885 |
| US-20140275506-A1 | ALKENYL GLYCOSIDES AND THEIR PREPARATION | FASN, UGCG, ST6GAL1 | ALDH1A1 99/4885F7 923/4885F3 1298/4885 |
| US-20160200756-A1 | Alkenyl Glycosides and Their Preparation | FASN, UGCG, ST6GAL1 | ALDH1A1 99/4885F7 923/4885F3 1298/4885 |
| US-20160215233-A1 | Maleinized Ester Derivatives | ADH5, MLEC, ADH1A | ALDH1A1 17/4885F7 336/4885F3 1054/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.